Skip to Content

Tag: Tekcapital


Also Noted

Belluscura cleared to launch POC

March 9, 2021HME News Staff

LONDON — Tekcapital has announced that its portfolio company Belluscura has been granted 510(k) clearance and marketing authorization by the U.S. Food and Drug Administration for its X-PLO2R portable oxygen concentrator. "We are excited to see that the FDA has cleared the X-PLO2R device for sale, as Tekcapital and Belluscura believe it could be helpful to patients during the COVID-19 pandemic, and for many of the 250 million people worldwide suffering from COPD," said Clifford Gross, PhD, executive...

Belluscura, Food & Drug Administration (FDA), Portable Oxygen Concentrator (POC), Tekcapital


Read Full Articlered right arrow icon